Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home ETF

Is Physical Gold the Ultimate Hedge? VanEck Merk Gold Trust Offers Unique Exposure

Robert Sasse by Robert Sasse
August 19, 2025
in ETF
0
VanEck Merk Gold Trust Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

As global uncertainty persists, investors continue turning to gold as a strategic store of value. The VanEck Merk Gold Trust (NYSE: OUNZ) stands out among precious metal ETFs by offering something rare—direct conversion to physical bullion.

Gold’s Market Dynamics

The yellow metal currently trades near $3,350 per ounce, consolidating after last year’s impressive rally. Three key drivers support gold prices:

  1. Escalating geopolitical tensions, particularly surrounding the Ukraine conflict
  2. Anticipated Federal Reserve rate cuts (85% probability priced in for September)
  3. Record central bank demand across emerging and developed markets

A Distinctive ETF Structure

Unlike conventional gold funds, OUNZ provides tangible asset ownership:

  • Each share represents precisely 481,682 ounces of gold (as of August 15)
  • Bullion stored under strict custody at JPMorgan Chase vaults
  • Exclusive physical redemption feature for shareholders

This pure-play approach eliminates sector concentration risks and country-specific exposures common in equity ETFs.

Should investors sell immediately? Or is it worth buying VanEck Merk Gold Trust?

Performance Metrics Reveal Strength

Recent returns demonstrate gold’s resilience:

  • Short-term dips: -1.77% (weekly) / -0.28% (monthly)
  • Strong quarterly gains: +4.52% (3 months)
  • Year-to-date surge: +25.96%
  • Annual outperformance: +33.93%

Liquidity remains robust with 797,067 shares traded daily (20-day average). The fund tracks the LBMA Gold Price PM benchmark with near-perfect precision, maintaining just 0.01% NAV deviation.

Competitive Landscape

While established players like SPDR Gold Shares (GLD) and iShares Gold Trust (IAU) dominate the space, OUNZ carves its niche through physical convertibility—a game-changer for investors seeking actual metal ownership rather than paper claims.

The fund’s unique redemption mechanism addresses a critical investor need: the ability to transform digital holdings into tangible wealth during market stress. As monetary policies shift and global risks multiply, this physical access feature may grow increasingly valuable.

Ad

VanEck Merk Gold Trust Stock: Buy or Sell?! New VanEck Merk Gold Trust Analysis from February 7 delivers the answer:

The latest VanEck Merk Gold Trust figures speak for themselves: Urgent action needed for VanEck Merk Gold Trust investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

VanEck Merk Gold Trust: Buy or sell? Read more here...

Tags: VanEck Merk Gold Trust
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Ishares Msci Acwi ETF Stock
Analysis

Global ETF Investors Await Crucial Index Reshuffle

February 6, 2026
iShares Global Clean Energy ETF Stock
AI & Quantum Computing

The AI Power Surge: Reshaping the Clean Energy Investment Thesis

February 4, 2026
iShares MSCI EAFE ETF Stock
Asian Markets

iShares MAFE ETF Reaches Fresh 52-Week Peak

February 3, 2026
Next Post
Johnson & Johnson Stock

Johnson & Johnson Shares Gain Momentum on Strong Earnings and Medical Breakthroughs

Unitedhealth Stock

Warren Buffett Bets Big on Troubled Healthcare Giant UnitedHealth

Livent Stock

Rio Tinto's Lithium Power Play: How a $6.7B Acquisition Reshapes the Battery Materials Race

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com